Kringle Pharma, Inc.'s total assets for Q3 2025 were ¥2.11B, a decrease of -7.94% from the previous quarter. JP:4884 total liabilities were ¥719.58M for the fiscal quarter, a 5.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.